Gold prices slip lower; consolidating after recent gains
Inspira Technologies Oxy BHN Ltd. (IINN) stock has reached a new 52-week low, trading at $0.76. With a market capitalization of $18.7 million, the company maintains a "Fair" financial health score according to InvestingPro analysis. This latest price point marks a significant downturn for the company, which has experienced a -59.47% change over the past year. Investors are closely monitoring the medical technology firm, known for its innovative respiratory support technology, as it navigates through a challenging period marked by this notable decline in stock value. The company’s performance and future outlook remain under scrutiny as it hits this low-water mark in its market valuation.
In other recent news, Inspira Technologies OXY B.H.N. Ltd. has announced promising initial results from their collaboration with Ennocure MedTech Ltd. The companies have developed a novel bio-electronic patch that demonstrated a 95% reduction in bacterial presence within four hours on porcine skin models, maintaining effectiveness over a 24-hour period. This innovative technology utilizes physical electric stimulation to prevent bacterial growth, offering a non-chemical approach to infection prevention. The patch is designed to enhance traditional IV dressings by preventing bacterial growth and providing real-time monitoring capabilities. Inspira’s CEO, Dagi Ben-Noon, highlighted the potential benefits for the 250,000 patients who suffer from bloodstream infections related to intravenous lines each year. The efficacy of the patch was validated against standardized antimicrobial performance protocols, including the AATCC TM100 standard. While these findings mark a significant step forward, it is important to note that the patch has not yet received regulatory approval. These developments are based on a press release statement from Inspira Technologies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.